Athenahealth Confirms $5.7B Buyout, Reports Solid Q3 ... Prior to the impact of new revenue recognition standard, total revenue was $331.4 million, up from $304.6 million in Q3 2017, non-GAAP operating income was $54.6 million compared to $39.5 million ATHN Historical Stock Prices ATHN (ATHN) has the following price history information. Looking back at ATHN historical stock prices for the last five trading days, on February 05, 2019, ATHN opened at $134.94, traded as high as $134.94 and as low as $134.80, and closed at $134.86. Trading volume was a total of 169.50K shares. On February 06, 2019, ATHN opened at $134.90, traded as high as $134.90 and as low as $134.85, and ATHN - Athenahealth Stock Price History - Barchart.com Historical daily price data is available for up to two years. For more data, Barchart Premier members can download more historical data (going back to Jan. 1, 1980) and can download Intraday, Daily, Weekly, Monthly or Quarterly data on the Historical Download tab.Additional underlying chart data and study values can be downloaded using the Interactive Charts.
Athenahealth, Inc (ATHN) Stock Is Flatlining. Time to ...
Position Close Update: athenahealth Inc. (ATHN) - New ... Aug 23, 2018 ATHN: NA - Earnings News & Analysis - Zacks Investment ... ATHN: NA - Earnings Announcements. Stay up to date with lastest Earnings Announcements for NA from Zacks Investment Research Athenahealth - ATHN - Stock Price & News | The Motley Fool Athenahealth ATHN. ATHN. View Interactive ATHN Charts. The Company is a provider of internet-based business services for physician practices. Interactive Chart. 1W 1M 3M 6M YTD 1Y 5Y 10Y MAX. ATHN - Short The Buyer Shut Off Pattern | Shadow Trader
Aug 23, 2018
Pre-Open Movers 09/18: (VKTX) (NXEO) (TLRY) Higher; (MDGL ... Today's Pre-Open Movers. Viking Therapeutics, Inc. (NASDAQ: VKTX) 120.7% HIGHER; announced positive top-line results from a 12-week Phase 2 study of VK2809, its novel liver-selective thyroid AMRN | Amarin Corp. PLC ADR Overview | MarketWatch Amarin Corp. PLC ADR. Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health.
ATHN -- Is Its Stock Price A Worthy Investment? Learn More.
ATHN Stock Quote - athenahealth Inc - Bloomberg Markets
athenahealth, Inc (NASDAQ:ATHN) released its quarterly earnings results on Thursday, April, 26th. The health services provider reported $1.25 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.53.
Actinium Pharmaceuticals. ATNM 0.34 0.02 (6.25%). NYSE Updated Jun 9, 2020 8:50 AM